Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study
ConclusionsLonger duration of CM therapy could be considered a protective factor of cancer recurrence and metastasis. CM treatment is associated with improving survival outcomes of postoperative NSCLC patients in China. (Registration No. ChiCTR-OOC-14005398)
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Internal Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Study